Data spanning the past 90 days through January 10, 2026 reveals that Bicycle Therapeutics's three principal insider shareholders consist of Director Bros. Advisors Lp Baker (10.02Mn shares), Chief Executive Officer Kevin Lee (619.00K shares), Director Gregory Paul Winter (196.43K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Bros. Advisors Lp Baker | 10,018,674 | 06 Jan, 2026 | |
| Kevin Lee | Chief Executive Officer | 618,996 | 06 Jan, 2026 |
| Gregory Paul Winter | 196,427 | 06 Jan, 2026 | |
| Michael Skynner | Chief Technology Officer | 161,966 | 06 Jan, 2026 |
| Alistair Milnes | Chief Operating Officer | 136,717 | 06 Jan, 2026 |
| Michael Charles Ferguson Hannay | Chief Prod & Supply Chain Off | 97,908 | 06 Jan, 2026 |
| Alethia Young | Chief Financial Officer | 87,081 | 06 Jan, 2026 |
| Santiago Arroyo | Chief Development Officer | 69,057 | 06 Jan, 2025 |
| Travis Alvin Thompson | Chief Accounting Officer | 66,265 | 06 Jan, 2026 |
| Nicholas Keen | Chief Scientific Officer | 62,024 | 08 Jul, 2024 |
| Nigel Crockett | Chief Business Officer | 51,053 | 06 Jan, 2025 |
| Pierre Legault | 46,000 | 06 Jan, 2025 | |
| Kate Bingham | 38,708 | 20 Jul, 2021 | |
| Dominic Smethurst | Chief Medical Officer | 36,699 | 05 Jan, 2023 |
| Janice Bourque | 32,500 | 06 Jan, 2026 | |
| Jose-Carlos Gutierrez-Ramos | 32,500 | 06 Jan, 2026 | |
| Lee Kalowski | President And Cfo | 30,309 | 05 Apr, 2023 |
| Stephen H. Sands | 26,893 | 06 Jan, 2026 | |
| Richard N Kender | 23,000 | 06 Jan, 2025 | |
| Alessandro Riva | 19,880 | 06 Jan, 2026 | |
| Robert Charles Swanton | 19,213 | 06 Jan, 2026 | |
| Veronica Gh Jordan | 16,750 | 04 Jan, 2024 | |
| Herve Hoppenot | 15,532 | 06 Jan, 2026 | |
| Roger D Dansey | 15,532 | 06 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Jan, 2026 | Michael Skynner | Ordinary Shares | D | 3,266 | $6.46 | 161,966 | D | S |
| 05 Jan, 2026 | Kevin Lee | Ordinary Shares | D | 10,989 | $6.46 | 618,996 | D | S |
| 05 Jan, 2026 | Alistair Milnes | Ordinary Shares | D | 3,416 | $6.46 | 136,717 | D | S |
| 05 Jan, 2026 | Alethia Young | Ordinary Shares | D | 1,878 | $6.54 | 87,081 | D | S |
| 05 Jan, 2026 | Alethia Young | Ordinary Shares | D | 2,456 | $6.45 | 88,959 | D | S |
| 05 Jan, 2026 | Travis Alvin Thompson | Ordinary Shares | D | 1,115 | $6.45 | 66,265 | D | S |
| 05 Jan, 2026 | Michael Charles Ferguson Hannay | Ordinary Shares | D | 2,367 | $6.45 | 97,908 | D | S |
| 02 Jan, 2026 | Bros. Advisors Lp Baker | American Depositary Shares | A | 19,000 | $0.00 | 10,018,674 | I | A |
| 02 Jan, 2026 | Bros. Advisors Lp Baker | American Depositary Shares | A | 19,000 | $0.00 | 937,483 | I | A |
| 02 Jan, 2026 | Herve Hoppenot | Ordinary Shares | A | 3,032 | $0.00 | 15,532 | D | A |
| 02 Jan, 2026 | Jose-Carlos Gutierrez-Ramos | Ordinary Shares | A | 9,500 | $0.00 | 32,500 | D | A |
| 02 Jan, 2026 | Roger D Dansey | Ordinary Shares | A | 3,032 | $0.00 | 15,532 | D | A |
| 02 Jan, 2026 | Michael Skynner | Ordinary Shares | D | 3,045 | $6.80 | 165,232 | D | S |
| 02 Jan, 2026 | Michael Skynner | Ordinary Shares | A | 50,000 | $0.00 | 168,277 | D | A |
| 02 Jan, 2026 | Kevin Lee | Ordinary Shares | A | 165,000 | $0.00 | 640,310 | D | A |
| 02 Jan, 2026 | Kevin Lee | Ordinary Shares | D | 10,325 | $6.80 | 629,985 | D | S |
| 02 Jan, 2026 | Gregory Paul Winter | Ordinary Shares | A | 9,500 | $0.00 | 196,427 | D | A |
| 02 Jan, 2026 | Janice Bourque | Ordinary Shares | A | 9,500 | $0.00 | 32,500 | D | A |
| 02 Jan, 2026 | Alessandro Riva | Ordinary Shares | A | 7,380 | $0.00 | 19,880 | D | A |
| 02 Jan, 2026 | Alistair Milnes | Ordinary Shares | D | 3,244 | $6.80 | 140,133 | D | S |